Bespoke Extracts (BSPK) Free Cash Flow (2011 - 2025)
Bespoke Extracts' (BSPK) quarterly Free Cash Flow came in at -$19620.0 in Q3 2025, up 30.78% year-on-year from -$15001.8 in Q3 2024, and up 36.71% quarter-over-quarter from -$31002.0 in Q2 2025.
Bespoke Extracts (BSPK) Free Cash Flow (2011 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Free Cash Flow across 15 years of filings, most recently posting -$19620.0 for Q3 2025.
- Free Cash Flow for Q3 2025 came in at -$19620.0, up 30.78% year-over-year; the trailing twelve-month figure through Sep 2025 was -$259702.0 (down 49.74% YoY), and the FY2024 annual result was -$289802.0, up 30.2% from the prior year.
- Free Cash Flow came in at -$19620.0 for Q3 2025 at Bespoke Extracts, up from -$31002.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $7010.0 in Q3 2023 to a low of -$633423.0 in Q3 2021.
- The 5-year median for Free Cash Flow is -$136140.0 (2024), against an average of -$161578.3.
- Across the five-year window, Free Cash Flow jumped 104.02% in 2023 and tumbled 588.69% in 2024, its largest moves.
- Bespoke Extracts' Free Cash Flow stood at -$29882.0 in 2021, then slumped by 547.24% to -$193407.0 in 2022, then surged by 89.78% to -$19768.0 in 2023, then sank by 588.69% to -$136140.0 in 2024, then jumped by 85.59% to -$19620.0 in 2025.
- The last three Free Cash Flow figures came in at -$19620.0 (Q3 2025), -$31002.0 (Q2 2025), and -$72940.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | -19,620.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -19,620.00 |
| Sep 30, 2025 | -19,620.00 |
| Jun 30, 2025 | -31,002.00 |
| Jun 30, 2025 | -31,002.00 |
| Mar 31, 2025 | -72,940.00 |
| Mar 31, 2025 | -72,940.00 |
| Dec 31, 2024 | -136,140.00 |
| Dec 31, 2024 | -136,140.00 |
| Sep 30, 2024 | -28,346.00 |
| Sep 30, 2024 | -28,346.00 |
| Jun 30, 2024 | -28,125.00 |
| Jun 30, 2024 | -28,125.00 |
| Mar 31, 2024 | -97,191.00 |
| Mar 31, 2024 | -97,191.00 |
| Dec 31, 2023 | -19,768.00 |
| Dec 31, 2023 | -19,768.00 |
| Sep 30, 2023 | 7,010.00 |
| Sep 30, 2023 | 7,010.00 |
| Jun 30, 2023 | -195,372.00 |
| Jun 30, 2023 | -195,372.00 |